Abstract
We have previously shown that flutamide (specific antagonist of the androgen receptor) has antihypertensive effects. In the present study we examined the mechanisms of flutamide action in the vasculature. The vascular effects of flutamide were assayed in aortae isolated from male or female Sprague-Dawley rats and from rats or mice lacking a functional androgen receptor (tfm, testicular feminization mutation). The effect of flutamide on coronary flow was tested in isolated hearts. In addition, male hypertensive rats with tfm mutation were treated with flutamide, and blood pressure was monitored. Flutamide induced a relaxation of rat aortae from all the strains used (maximum relaxation at 10 µM: 51.3±5.2% of phenylephrine contraction) and increased the coronary flow. The aortic relaxation to flutamide was abolished by endothelium removal, or by inhibition of nitric oxide synthase, guanylyl cyclase, and tyrosine kinase but not by calmodulin inhibition. Flutamide treatment attenuated the development of hypertension in mouse renin transgenic rats with the tfm mutation. Flutamide produces direct vasodilation by inducing release of NO from the endothelium and causes subsequent activation of soluble guanylyl cyclase in an active androgen receptor independent manner. This response may contribute to the observed antihypertensive actions of flutamide.
Similar content being viewed by others
Abbreviations
- L-NAME :
-
N G-Nitro-l-arginine methylester
- MAPK :
-
Mitogen activated protein kinase
- NOS :
-
Nitric oxide synthase
- SD :
-
Sprague-Dawley
- tfm :
-
Testicular feminization mutation
References
Hayward CS, Webb CM, Collins P (2001) Effect of sex hormones on cardiac mass. Lancet 357:1354–1356
Reckelhoff JF, Granger JP (1999) Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol 26:127–131
Reckelhoff JF (2001) Gender differences in the regulation of blood pressure. Hypertension 37:1199–1208
Baltatu O, Cayla C, Iliescu R, Andreev D, Bader M (2003) Abolition of end-organ damage by antiandrogen treatment in female hypertensive transgenic rats. Hypertension 41:830–833
Baltatu O, Cayla C, Iliescu R, Andreev D, Jordan C, Bader M (2002) Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol 13:2681–2687
Jones RD, English KM, Pugh PJ, Morice AH, Jones TH, Channer KS (2002) Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J Cardiovasc Pharmacol 39:814–823
Caplea A, Seachrist D, Dunphy G, Ely D (2001) Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade. Am J Physiol Heart Circ Physiol 280:H1793–H1801
Reckelhoff JF, Zhang H, Srivastava K, Granger JP (1999) Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34:920–923
Kumai T, Tanaka M, Tateishi T, Watanabe M, Nakura H, Asoh M, Kobayashi S (1998) Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol 357:620–624
Ganten U, Schroder G, Witt M, Zimmermann F, Ganten D, Stock G (1989) Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J Hypertens 7:721–726
Langendorff O (1895) Untersuschungen am überlebenden Säugertierherzen. Pflugers Arch 61:291–307
Stromer H, Cittadini A, Szymanska G, Apstein CS, Morgan JP (1997) Validation of different methods to compare isovolumic cardiac function in isolated hearts of varying sizes. Am J Physiol 272:H501–H510
Baltatu O, Janssen BJ, Bricca G, Plehm R, Monti J, Ganten D, Bader M (2001) Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen. Hypertension 37:408–413
Bohlender J, Menard J, Edling O, Ganten D, Luft FC (1998) Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats. Am J Physiol 274:H1450–H1456
Brogden RN, Chrisp P (1991) Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer. Drugs Aging 1:104–115
De L, V, Lanzetta D, D'Antona D, La Marca A, Morgante G (1998) Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:99–102
Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W, Bartholomew M (1990) Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 54:255–259
Reckelhoff JF, Zhang H, Srivastava K (2000) Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 35:480–483
Chen YF, Naftilan AJ, Oparil S (1992) Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19:456–463
Gregg DE (1963) Effect of coronary perfusion pressure and coronary flow on oxygen usage of the myocardium. Circ Res 13:497–500
Karunanithi MK, Young JA, Kalnins W, Kesteven S, Feneley MP (1999) Response of the intact canine left ventricle to increased afterload and increased coronary perfusion pressure in the presence of coronary flow autoregulation. Circulation 100:1562–1568
Maggiolini M, Donze O, Jeannin E, Ando S, Picard D (1999) Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Cancer Res 59:4864–4869
Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P (1995) Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91:1154–1160
Costarella CE, Stallone JN, Rutecki GW, Whittier FC (1996) Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther 277:34–39
Ding AQ, Stallone JN (2001) Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation. J Appl Physiol 91:2742–2750
Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ (2001) Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 281:H1720–H1727
Tep-areenan P, Kendall DA, Randall MD (2002) Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol 135:735–740
Muller MJ, Baer HP (1983) Relaxant effects of forskolin in smooth muscle. Role of cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol 322:78–82
Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R (2000) An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97:9747–9752
Fleming I, Bauersachs J, Busse R (1997) Calcium-dependent and calcium-independent activation of the endothelial NO synthase. J Vasc Res 34:165–174
Fleming I, Busse R (1999) Signal transduction of eNOS activation. Cardiovasc Res 43:532–541
Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC (1999) Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18:6322–6329
Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW (1999) Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401–406
Ba ZF, Wang P, Kuebler JF, Rue LW III, Bland KI, Chaudry IH (2002) Flutamide induces relaxation in large and small blood vessels. Arch Surg 137:1180–1186
Acknowledgements
This work was supported in part by the German Bundesministerium für Bildung und Forschung (grant 0310681B). We thank Irene Strauss and Gabriele Born for the measurement of plasma hormone levels and Lieselotte Winkler for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iliescu, R., Campos, L.A., Schlegel, WP. et al. Androgen receptor independent cardiovascular action of the antiandrogen flutamide. J Mol Med 81, 420–427 (2003). https://doi.org/10.1007/s00109-003-0449-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-003-0449-4